Lifecore Biomedical, Inc. splits its revenue into 2 lines in its filings. The largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Contract Development And Manufacturing Organization at $17.8 million, 70% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Sep 30, 2026
|
Q3 FY2026
Sep 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Sep 30, 2025
|
Q4 FY2025
May 25, 2025
|
Q3 FY2025
Feb 23, 2025
|
Q2 FY2025
Nov 24, 2024
|
Q1 FY2025
Aug 25, 2024
|
Q4 FY2024
May 26, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
119
|
25
|
34
|
31
|
36
|
35
|
33
|
25
|
38
|
| Contract Development And Manufacturing Organization |
—
|
18
-14.5%
share 70.2%
|
16
share 45.5%
|
22
+7.8%
share 69.9%
|
24
share 64.5%
|
21
share 59.1%
|
—
|
20
share 81.7%
|
—
|
| HA Manufacturing |
—
|
8
-47.5%
share 29.8%
|
19
share 54.5%
|
9
+106.9%
share 30.1%
|
13
share 35.5%
|
14
share 40.9%
|
—
|
5
share 18.3%
|
—
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LFCR (Nasdaq)
- Fiscal year ends
- May 25
- Incorporated in
- DE
- Headquarters
- Chaska, MN
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1005286
- Former names
- LANDEC CORP \CA\ (until Nov 7, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.